Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Impurity Profiling

Posted on By

SOP for Impurity Profiling

Procedure for Impurity Profiling

1) Purpose

The purpose of this SOP is to outline the procedure for conducting impurity profiling of Active Pharmaceutical Ingredients (APIs) to ensure their purity and compliance with regulatory standards.

2) Scope

This SOP applies to all APIs used in pharmaceutical manufacturing within the facility that require impurity profiling as per regulatory requirements.

3) Responsibilities

Quality Control (QC) Department: Responsible for performing impurity profiling and ensuring compliance with this SOP.
Production Department: Responsible for providing API samples and supporting QC during impurity profiling.

4) Procedure

4.1 Method Development and Validation:
    4.1.1 Develop and validate analytical methods for impurity profiling based on API characteristics.
    4.1.2 Validate method specificity, sensitivity, accuracy, and precision according to ICH guidelines.
    4.1.3 Document method validation results and obtain approval from QC Manager.

See also  SOP for Tablet Thickness Measurement

4.2 Sample Handling and Preparation:
    4.2.1 Obtain representative samples of the API from the production department or quarantine area.
    4.2.2 Ensure samples are properly identified, labeled, and stored under appropriate conditions.
    4.2.3 Prepare sample solutions or suspensions as per validated methods and dilutions if necessary.

4.3 Impurity Profiling Procedure:
    4.3.1 Perform impurity profiling using validated analytical techniques, such as HPLC, GC, LC-MS, or NMR.
    4.3.2 Separate and quantify impurities present in the API sample using appropriate chromatographic

or spectroscopic methods.
    4.3.3 Compare impurity profiles against reference standards or previous batches to identify and characterize impurities.
    4.3.4 Document chromatograms, spectra, or other relevant data as per method requirements.

See also  SOP for Clarity and Opalescence Testing of Liquids

4.4 Calculation and Interpretation:
    4.4.1 Calculate the percentage of impurities relative to the API concentration using validated formulas.
    4.4.2 Evaluate impurity levels against acceptance criteria specified in pharmacopeial standards or internal specifications.
    4.4.3 Investigate and document any unexpected impurities or deviations from expected results.

4.5 Acceptance Criteria:
    4.5.1 API impurity levels should be within acceptable limits defined by regulatory authorities and internal quality standards.
    4.5.2 Ensure all analytical controls and method validation parameters meet predefined criteria.

4.6 Documentation:
    4.6.1 Record all impurity profiling procedures, results, and observations in the Impurity Profiling Record.
    4.6.2 Maintain detailed records of method development, sample preparation, testing conditions, and any deviations encountered.
    4.6.3 Review and approve the documentation by QC Manager.

See also  SOP for Pen Injector Functionality Testing

5) Abbreviations, if any

QC: Quality Control
API: Active Pharmaceutical Ingredient
HPLC: High Performance Liquid Chromatography
GC: Gas Chromatography
LC-MS: Liquid Chromatography-Mass Spectrometry
NMR: Nuclear Magnetic Resonance

6) Documents, if any

Impurity Profiling Record
Method Validation Report for Impurity Profiling
Sampling Plan Document

7) Reference, if any

ICH guidelines for Analytical Method Validation
Pharmacopeial standards for Impurity Profiling of APIs

8) SOP Version

Version 1.0

In-Process Control Tags:Blend uniformity testing SOP, Bulk density testing SOP, Capsule content uniformity SOP, Capsule disintegration testing SOP, Capsule dissolution testing SOP, Capsule weight variation SOP, Clarity and opalescence testing of liquids SOP, Endotoxin testing in injectable products SOP, Flowability testing of powders SOP, Granulation size distribution SOP, Moisture content determination in granules SOP, Osmolality testing SOP, Particulate matter testing in liquids SOP, pH measurement of solutions SOP, Pyrogen testing SOP, Specific gravity testing of liquids SOP, Sterility testing SOP, Tablet disintegration testing SOP, Tablet dissolution testing SOP, Tablet friability testing SOP, Tablet hardness testing SOP, Tablet thickness measurement SOP, Tablet weight variation SOP, Uniformity of dosage units SOP, Viscosity testing of liquids SOP

Post navigation

Previous Post: SOP for Calibration and Maintenance: Procedures for Calibrating and Maintaining Equipment
Next Post: SOP for Labeling of Vials

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version